Posts by admin
CJC-1295 / Ipamorelin Body Composition Data: What the Clinical Evidence Actually Shows
Setting Expectations Before Reviewing the Evidence
CJC-1295 and ipamorelin are widely used in physician-supervised practice for body c...
CJC-1295 + Ipamorelin: Oral Spray vs Nasal vs Injection — Bioavailability, Delivery, and Practice Fit
The Growing Delivery-Options Conversation
CJC-1295 and ipamorelin — used individually and in combination — are among the most widely p...
BPC-157 Clinical Research Review: Preclinical Tissue Repair and Emerging Human Data
The State of the Literature
BPC-157 has one of the larger preclinical literatures of any short-chain peptide in physician-directed pra...
BPC-157 After the April 2026 FDA Bulk Drug Substances Update
Why This Moment Matters
The April 2026 FDA action on 503A bulk drug substance peptides materially changed the compounding landscape fo...
BPC-157 Mechanism of Action: Angiogenesis, Nitric Oxide, and Anti-Inflammatory Pathways
A Compound Without a Single Receptor
One of the defining features of the BPC-157 literature is that there is no single, cleanly identi...
BPC-157: What Is the Gastric-Derived Pentadecapeptide? Origin, Structure, and Mechanism
What BPC-157 Actually Is
BPC-157 is a synthetic 15-amino-acid peptide — a pentadecapeptide — derived from the sequence of a larger pro...
SLU-PP-332 vs MOTS-c: Comparing Exercise Mimetics for Metabolic Medicine
Two Compounds, Two Very Different Approaches
SLU-PP-332 and MOTS-c are both discussed under the umbrella of "exercise mimetics" — comp...
SLU-PP-332 FDA Approval Status and 2026 Regulatory Outlook
The Short Answer
As of 2026, SLU-PP-332 is not FDA-approved for any indication. It is not present on the FDA 503A bulk drug substances...
SLU-PP-332 Phase 1 Human Trial: Status, Timeline, and What ClinicalTrials.gov Shows
The Snapshot
As of mid-2026, SLU-PP-332 has not completed a well-characterized phase 1 human clinical trial with published results. Ac...
SLU-PP-332 and Heart Rate: Understanding the Tachycardia Signal
Why This Question Keeps Surfacing
Of the observational data from SLU-PP-332 preclinical studies, one cardiovascular finding has gotten...